Pregnancy outcome after exposure to injectable ribavirin during embryogenesis

We describe normal pregnancy outcome in a case of first trimester exposure to injectable ribavirin in a 36-year-old pregnant woman who received three intramuscular injections of ribavirin for suspected SARS. She delivered at 40 weeks of gestation a healthy baby girl. In pediatric follow up at 8 mont...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezvani, Massoud, Koren, Gideon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2006
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134815/
https://www.ncbi.nlm.nih.gov/pubmed/16122903
http://dx.doi.org/10.1016/j.reprotox.2005.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134815/
https://www.ncbi.nlm.nih.gov/pubmed/16122903
http://dx.doi.org/10.1016/j.reprotox.2005.06.005

Ejemplares similares